E Antunes Selected Research

E Antunes Research Topics

Disease

5	Inflammation (Inflammations) 01/2021 - 08/2001
5	Edema (Dropsy) 03/2019 - 02/2000
3	Necrosis 02/2010 - 03/2000
2	Erectile Dysfunction 11/2021 - 03/2013
2	Body Weight (Weight, Body) 02/2010 - 03/2000
2	Hypertension (High Blood Pressure) 03/2007 - 03/2000
2	Tachycardia (Tachyarrhythmias) 07/2000 - 05/2000
1	Prostatic Diseases 11/2021
1	Lower Urinary Tract Symptoms 11/2021
1	Prostatitis 11/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2021
1	Pleurisy (Pleuritis) 03/2019
1	Overactive Urinary Bladder (Overactive Bladder) 02/2016
1	Acute Lung Injury 09/2015
1	Pancreatitis 05/2014
1	Hyperamylasemia 05/2014
1	Hyperalgesia 05/2014
1	Abdominal Pain (Pain, Abdominal) 05/2014
1	Premature Ejaculation 08/2012
1	Infections 07/2012
1	Vascular Diseases (Vascular Disease) 07/2012
1	Glucose Intolerance 02/2010
1	Obesity 02/2010
1	Pulmonary Hypertension 06/2008
1	Reperfusion Injury 03/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2005
1	Myotoxicity 12/2003
1	Pain (Aches) 12/2003
1	Snake Bites (Snake Bite) 12/2003
1	Arthritis (Polyarthritis) 11/2000

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2014 - 03/2000
3	VenomsIBA 05/2014 - 06/2001
3	Secretory Phospholipases A2IBA 05/2014 - 02/2000
2	staphylococcal enterotoxin BIBA 01/2021 - 07/2000
2	CarrageenanIBA 03/2019 - 06/2001
2	coumarinIBA 03/2019 - 07/2010
2	CytokinesIBA 09/2015 - 02/2010
2	InterleukinsIBA 02/2010 - 03/2008
2	LipidsIBA 02/2010 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 12/2003
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2007 - 03/2000
2	2,5-dichloro-4-bromophenol (B 2)IBA 06/2001 - 07/2000
2	icatibantIBA 06/2001 - 07/2000
2	KininsIBA 06/2001 - 11/2000
2	BradykininIBA 06/2001 - 07/2000
1	ResveratrolIBA 11/2021
1	p-Methoxy-N-methylphenethylamineIBA 03/2019
1	mirabegronIBA 02/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2016
1	ChemokinesIBA 09/2015
1	Integrin alpha4beta1 (VLA-4)IBA 09/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2014
1	Peroxidase (Myeloperoxidase)IBA 05/2014
1	NitritesIBA 05/2014
1	3-nitrotyrosineIBA 05/2014
1	Amylases FDA Link 05/2014
1	NitratesIBA 05/2014
1	BAY 73-6691IBA 03/2013
1	Soluble Guanylyl CyclaseIBA 08/2012
1	3- (4- Amino- 5- cyclopropylpyrimidine- 2- yl)- 1- (2- fluorobenzyl)- 1H- pyrazolo(3,4- b)pyridineIBA 07/2012
1	Pharmaceutical PreparationsIBA 07/2012
1	ethyl 2-oxo-2H-chromene-3-carboxylateIBA 07/2010
1	4-bromophenacyl bromideIBA 07/2010
1	LeptinIBA 02/2010
1	AdiponectinIBA 02/2010
1	Interleukin-10 (Interleukin 10)IBA 02/2010
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2008
1	Phosphodiesterase 5 InhibitorsIBA 06/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2008
1	Superoxide DismutaseIBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008
1	Kininogens (Kininogen)IBA 01/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2003
1	Arachidonic Acid (Vitamin F)IBA 12/2003
1	EnzymesIBA 12/2003
1	AllergensIBA 08/2001
1	Lipoxygenase InhibitorsIBA 06/2001
1	Indomethacin (Indometacin)FDA LinkGeneric 06/2001
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 06/2001
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2001
1	Pyrilamine (Mepyramine)FDA Link 06/2001
1	Histamine Receptors (Histamine Receptor)IBA 06/2001
1	Serotonin (5 Hydroxytryptamine)IBA 06/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2001
1	Cyproheptadine (Periactin)FDA Link 06/2001
1	Captopril (Capoten)FDA LinkGeneric 06/2001
1	Iloprost (Ventavis)FDA Link 06/2001
1	Lipoxygenase (Lipoxygenase-1)IBA 06/2001
1	Cyclooxygenase InhibitorsIBA 06/2001
1	BenzamidesIBA 06/2001
1	Antivenins (Antivenoms)IBA 06/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2001
1	parsalmideIBA 06/2001
1	Bothrops jararaca VenomIBA 11/2000

Therapy/Procedure

2	Therapeutics 07/2012 - 05/2000
2	Catheter Ablation 07/2000 - 05/2000
1	Oral Administration 03/2019
1	Intravenous Administration 06/2001